Antiarrhythmic Drugs Market: Atrial Fibrillation Management, Class...

добавлена новая статья Wellness

2026-11-06 06:16:19 - Перевод -

Antiarrhythmic Drugs Market: Atrial Fibrillation Management, Class III Potassium Channel Blockers, and Targeted Antiarrhythmics Driving Growth

Rising global prevalence of cardiovascular diseases, expanding geriatric demographics susceptible to cardiac arrhythmias, and continuous pharmaceutical developments in ion channel-targeted antiarrhythmic agents are driving robust growth across the global Antiarrhythmic Drugs Market. Antiarrhythmic drugs—classified under the Vaughan Williams framework into Class I (sodium channel...

0 Комментарии 0 Поделились 66 Просмотры 0 предпросмотр